NCT00426270View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

Octagam 10%

Octagam 10% was supplied as a ready-to-use solution in glass bottles.

Trial Locations (1)

Unknown

Contact Octapharma for information, Vienna

Sponsors

Lead Sponsor

Octapharma
All Listed Sponsors
lead

Octapharma

INDUSTRY